• News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
    • Scientific Presentations
  • Investors
    • Overview
    • News
    • Analyses
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Board and Management
    • The Share
    • Financial Reports
      • Financial Reports - English
      • Financial Reports – Swedish
      • Financial Calendar
    • Corporate Governance
    • General Meetings
    • IR Contact
  • Career
  • Contact
logo
  • News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
    • Scientific Presentations
  • Investors
    • Overview
    • News
    • Analyses
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Board and Management
    • The Share
    • Financial Reports
      • Financial Reports - English
      • Financial Reports – Swedish
      • Financial Calendar
    • Corporate Governance
    • General Meetings
    • IR Contact
  • Career
  • Contact
Home / Investors / Analyses
  • Overview
  • News
  • Analyses
  • Press Releases
    • English
    • Swedish
    • Subscribe
  • Presentations
  • Board and Management
  • The Share
  • Financial Reports
    • Financial Reports - English
    • Financial Reports – Swedish
    • Financial Calendar
  • Corporate Governance
  • General Meetings
  • IR Contact

Analyses

Redeye Analyst Coverage

Redeye AB
Kevin Sule – Equity Research Analyst
Phone: +46 720 92 18 87
E-mail: kevin.sule@redeye.se

DNB Carnegie Analyst Coverage

DNB Carnegie Investment Bank AB
Ludvig Svensson – Commissioned Research
Phone: +46 704 96 25 35
E-mail: ludvig.svensson@carnegie.se

Company site at Carnegie Investment Bank

Analysis 8 April 2025 View pdf

Analysis 19 February 2025 View pdf

Analysis 27 January 2025 View pdf

Analysis 15 May 2024 (Swedish). View pdf

Analysis 29 February 2024 (Swedish). View pdf

Analysis 21 November 2023 (Swedish). View pdf 

Analysis 21 November 2023 (English). View pdf 

Additional Analyst Coverage

Additional Equity Research by Carlsquare

Analysis in Swedish 

  • News
  • Our Company
  • Patients & Families
  • R & D
  • Investors
  • Contact

Alzinova AB, Gemenskapens gata 9,  SE-431 53 Mölndal
info@alzinova.com

Follow us on

follow us on linkedin